Reducing Contrast Agent Dose in Cardiovascular MR Angiography with Deep Learning.

Journal: Journal of magnetic resonance imaging : JMRI
PMID:

Abstract

BACKGROUND: Contrast-enhanced magnetic resonance angiography (MRA) is used to assess various cardiovascular conditions. However, gadolinium-based contrast agents (GBCAs) carry a risk of dose-related adverse effects.

Authors

  • Javier Montalt-Tordera
    Centre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, University College London, London, WC1N 1EH, UK.
  • Michael Quail
    UCL Centre for Cardiovascular Imaging, Institute of Cardiovascular Science, University College London, 30 Guildford Street, London, WC1N 1EH, UK.
  • Jennifer A Steeden
    UCL Centre for Cardiovascular Imaging, University College London, London, United Kingdom.
  • Vivek Muthurangu
    UCL Centre for Cardiovascular Imaging, University College London, London, United Kingdom.